EGR1 and cancer: Reexpression of EGR1 in EGR1-deficient transformed cell lines limits cancer cell growth and tumorigenicity, suggesting a role for EGR1 in promoting the growth arrest of transformed cell variants [11]–[12], [3] and it also augments the sensitivity to chemotherapeutic treatments [13]–[15].